Want to create an interactive transcript for this episode?
Podcast: BioTech Nation ... with Dr. Moira Gunn
Episode: No More Transfusions!!! Dr. John Scarlett, President and CEO of Geron Corporation
Description: Dr. John Scarlett, President and CEO of Geron Corporation talks about their drug Imetelstat for myelodysplastic syndrome (MDS). MDS patients often require frequent blood transfusions, impacting their quality of life. Imetelstat, a telomerase inhibitor, aims to reduce transfusion dependence by targeting cancer cells in the bone marrow. Phase three trials showed promising results, with 40% of patients experiencing at least an 8-week transfusion-free interval.Â